申请人:UNIVERSITY COLLEGE CORK
公开号:US20150291640A1
公开(公告)日:2015-10-15
A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or prodrug thereof, wherein the groups are as defined in the claims. Further aspects of the invention relate to pharmaceutical compositions comprising compounds of formula (I), and the use of compounds of formula (I) in the preparation of a medicament for treating a viral disorder.
本发明的第一个方面涉及公式(I)的化合物,或其药学上可接受的盐或前药,其中所述的基团如权利要求所定义。本发明的其他方面涉及包含公式(I)化合物的制药组合物,以及使用公式(I)化合物制备治疗病毒性疾病药物的用途。